New recommendations from the American College of Rheumatology (ACR) for the treatment of rheumatoid arthritis (RA) were presented at the ACR annual meeting and published simultaneously online in Arthritis & Rheumatology and Arthritis Care & Research.
The strategy of treat-to-target (T2T) is paying off for patients with rheumatoid arthritis (RA) in daily clinical practice, according to a study presented at the 2015 annual meeting of the American College of Rheumatology (ACR).
The certification through portfolio process can be used to promote the rheumatology nurse’s professional development and performance, said Sheree C. Carter, PhD, RN, at the 2015 Annual Conference of the Rheumatology Nurses Society (RNS).
Patients who present with joint pain and who have traveled recently may be infected with the chikungunya virus, which can closely mimic rheumatoid arthritis (RA).
Sanofi US has announced that Winthrop US, its generic division, will begin providing an authorized generic version of Arava tablets indicated for the treatment of active rheumatoid arthritis in adults.
As the healthcare system in the United States moves slowly toward a value-based strategy, a recent online article noted that value-based care can lower costs and is certainly beneficial for insurers, including Medicare, but asked, “...does it bring benefits to physicians or patients?”
After reporting on the efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids in osteoarthritis at the 2015 Osteoarthritis Research Society International World Congress in Seattle, WA, Jeffrey Katz, MD, and colleagues have published online their findings on the cost-effectiveness of NSAIDs in the treatment of older patients with OA and multiple comorbidities.
Nevada has passed a new law designed to help recruit healthcare professionals to the state. As of July 1, the Expedited Licensure Bill allows medical professionals who are licensed and in good standing in another state to receive a license to practice in Nevada within 60 days.
The Centers for Disease Control and Prevention (CDC) has announced that The Lupus Initiative (TLI) will be given a 5-year grant to help fund programs designed to increase knowledge and awareness of systemic lupus erythematosus among primary care practitioners and people with as yet undiagnosed lupus as well as rheumatology healthcare providers.
Implementation of a multidisciplinary bone health team (BHT) improved rates of screening, diagnosis, and treatment initiation for osteopenia/osteoporosis in older veterans, compared with standard primary care.